These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8382349)

  • 1. 2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients.
    Berger AR; Arezzo JC; Schaumburg HH; Skowron G; Merigan T; Bozzette S; Richman D; Soo W
    Neurology; 1993 Feb; 43(2):358-62. PubMed ID: 8382349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible axonal neuropathy from the treatment of AIDS and related disorders with 2',3'-dideoxycytidine (ddC).
    Dubinsky RM; Yarchoan R; Dalakas M; Broder S
    Muscle Nerve; 1989 Oct; 12(10):856-60. PubMed ID: 2558314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose zalcitabine-related toxic neuropathy: frequency, natural history, and risk factors.
    Blum AS; Dal Pan GJ; Feinberg J; Raines C; Mayjo K; Cornblath DR; McArthur JC
    Neurology; 1996 Apr; 46(4):999-1003. PubMed ID: 8780079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Arceo R; Brosnan C; Arezzo J; Schaumburg H
    Lab Invest; 1992 Jan; 66(1):63-74. PubMed ID: 1309930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).
    Dalakas MC; Semino-Mora C; Leon-Monzon M
    Lab Invest; 2001 Nov; 81(11):1537-44. PubMed ID: 11706061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine.
    LeLacheur SF; Simon GL
    J Acquir Immune Defic Syndr (1988); 1991; 4(5):538-9. PubMed ID: 1849990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the rat.
    Chen X; Levine JD
    Mol Pain; 2007 Feb; 3():5. PubMed ID: 17319957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dideoxycytidine: current clinical experience and future prospects. A summary.
    Broder S; Yarchoan R
    Am J Med; 1990 May; 88(5B):31S-33S. PubMed ID: 2159708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.
    Ferrari LF; Levine JD
    Eur J Neurosci; 2010 Sep; 32(5):811-8. PubMed ID: 20726883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.
    Simpson DM; Tagliati M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):153-61. PubMed ID: 7749792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal RyR2 pathway regulated by the RNA-binding protein HuD induces pain hypersensitivity in antiretroviral neuropathy.
    Sanna MD; Peroni D; Quattrone A; Ghelardini C; Galeotti N
    Exp Neurol; 2015 May; 267():53-63. PubMed ID: 25765490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKC-mediated HuD-GAP43 pathway activation in a mouse model of antiretroviral painful neuropathy.
    Sanna MD; Quattrone A; Ghelardini C; Galeotti N
    Pharmacol Res; 2014 Mar; 81():44-53. PubMed ID: 24565699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sequential dideoxycytidine and zidovudine in advanced HIV-1 infection. Phase II study].
    Ruiz-Argüelles GJ; Lagunes-Yannelli B; Mercado-Díaz L
    Rev Invest Clin; 1993; 45(2):145-7. PubMed ID: 8393211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructure of peripheral neuropathy induced in rabbits by 2',3'-dideoxycytidine.
    Feldman D; Brosnan C; Anderson TD
    Lab Invest; 1992 Jan; 66(1):75-85. PubMed ID: 1309931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial schwannopathy and peripheral myelinopathy in a rabbit model of dideoxycytidine neurotoxicity.
    Anderson TD; Davidovich A; Feldman D; Sprinkle TJ; Arezzo J; Brosnan C; Calderon RO; Fossom LH; DeVries JT; DeVries GH
    Lab Invest; 1994 May; 70(5):724-39. PubMed ID: 7515130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA-binding protein HuD promotes spinal GAP43 overexpression in antiretroviral-induced neuropathy.
    Sanna MD; Quattrone A; Mello T; Ghelardini C; Galeotti N
    Exp Neurol; 2014 Nov; 261():343-53. PubMed ID: 24861443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical mechanistic basis of the toxic effects and efficacy of dideoxycytidine in HIV:AIDS.
    Akintonwa DA
    Med Hypotheses; 2001 Aug; 57(2):249-51. PubMed ID: 11461183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral neuropathy: zalcitabine reassessed.
    Carey P
    Int J STD AIDS; 2000 Jul; 11(7):417-23. PubMed ID: 10919481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time.
    Levine AM; Tulpule A; Espina B; Boswell W; Buckley J; Rasheed S; Stain S; Parker J; Nathwani B; Gill PS
    Cancer; 1996 Aug; 78(3):517-26. PubMed ID: 8697399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-human immunodeficiency virus type 1 therapy and peripheral neuropathy: prevention of 2',3'-dideoxycytidine toxicity in PC12 cells, a neuronal model, by uridine and pyruvate.
    Keilbaugh SA; Hobbs GA; Simpson MV
    Mol Pharmacol; 1993 Oct; 44(4):702-6. PubMed ID: 8232219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.